Innovotech Inc. (TSX VENTURE:IOT) is pleased to announce that effective March
10, 2008, Lorne Babiuk, PhD, has joined the Company's Board of Directors. Dr.
Babiuk has had an outstanding career in the research and development of novel
vaccines. He is currently Vice President (Research) at the University of Alberta
located in Edmonton. Prior to joining the University of Alberta, Dr Babiuk spent
over 30 years at the University of Saskatchewan where he was instrumental in the
growth of VIDO (Vaccine and Infectious Disease Organization) into a world
renowned centre for vaccine development.


"Dr Babiuk is a natural for our Board given his career experience in
microbiology. In addition, he is very well connected worldwide in the fields of
microbiology and infectious diseases" says Dr. Wolfgang Muhs, Chairman and CEO
of Innovotech. "We are thrilled to have Lorne on our Board".


About Innovotech Inc:

Innovotech is a product development company focusing on the development of
solutions to medical, agricultural and industrial problems caused by microbial
biofilms. Biofilms are protected communities of microorganisms which are very
common and very difficult to treat due to their inherent resistance. They have
been implicated in a host of devastating infections in agriculture, human health
and industry. No diagnostics or antibiotics are currently approved for use in
infections involving biofilms.


Innovotech (TSXV:IOT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Innovotech Charts.
Innovotech (TSXV:IOT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Innovotech Charts.